Sobetirome: Targeting Fat Metabolism and Neurological Disorders
Sobetirome, a synthetic thyroid hormone analog, selectively targets thyroid hormone receptor beta (TRβ) to offer therapeutic benefits in conditions like hypercholesterolemia without usual side effects. By sparing the alpha-receptors linked to cardiac concerns, sobetirome shows promise in lowering cholesterol and improving metabolic rates safely. Research continues to explore its efficacy and safety, aiming to leverage thyroid hormone benefits with reduced risks, highlighting its potential in treating lipid and neurological disorders.


